Antibiotic News and Research RSS Feed - Antibiotic News and Research

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.
NSF, NIH, USDA receive more than $12 million in new EEID grants

NSF, NIH, USDA receive more than $12 million in new EEID grants

Ebola, MERS (Middle East Respiratory Syndrome), malaria, antibiotic-resistant infections: Is our interaction with the environment somehow responsible for their increased incidence? [More]
Widespread use of unnecessary antibiotics drives up avoidable healthcare costs

Widespread use of unnecessary antibiotics drives up avoidable healthcare costs

The Centers for Disease Control and Prevention (CDC) and Premier, Inc. have released new research on the widespread use of unnecessary and duplicative antibiotics in U.S. hospitals, which could have led to an estimated $163 million in excess costs. [More]
Bacteria in fresh honey produce myriad of active antimicrobial compounds

Bacteria in fresh honey produce myriad of active antimicrobial compounds

Raw honey has been used against infections for millennia, before honey - as we now know it - was manufactured and sold in stores. So what is the key to its' antimicrobial properties? Researchers at Lund University in Sweden have identified a unique group of 13 lactic acid bacteria found in fresh honey, from the honey stomach of bees. [More]
Nearly half of hog workers carry livestock-associated bacteria to home

Nearly half of hog workers carry livestock-associated bacteria to home

A new study suggests that nearly half of workers who care for animals in large industrial hog farming operations may be carrying home livestock-associated bacteria in their noses, and that this potentially harmful bacteria remains with them up to four days after exposure. [More]
Chinese study of serogroup 6 S. pneumoniae finds no antibiotic-resistant clones

Chinese study of serogroup 6 S. pneumoniae finds no antibiotic-resistant clones

A survey of serogroup 6 Streptococcus pneumoniae isolates from children in China has identified no antibiotic-resistant clones, leading the authors to speculate that the isolates may be under antibiotic selective pressure. [More]
Researchers modify protocol to test dangerous form of antibiotic resistance

Researchers modify protocol to test dangerous form of antibiotic resistance

Researchers from Oregon State Public Health Lab have modified the protocol for a relatively new test for a dangerous form of antibiotic resistance, increasing its specificity to 100 percent. [More]
Antibiotic stewardship programs reduce hospital readmissions due to infection

Antibiotic stewardship programs reduce hospital readmissions due to infection

Antibiotic stewardship programs, which promote the appropriate use of antibiotics in hospitals and other healthcare centers, not only lead to reduction in antibiotic use with reduced adverse events, but also lead to significant savings. [More]
FDA provides QIDP designation to Debiopharm’s Debio 1450 for treatment of ABSSSI

FDA provides QIDP designation to Debiopharm’s Debio 1450 for treatment of ABSSSI

Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI). [More]
People with food allergies have to watch what their fruits and vegetables eat

People with food allergies have to watch what their fruits and vegetables eat

People with food allergies always have to watch what they eat. Now, they may have to watch what their fruits and vegetables eat, as it seems it's possible to have an allergic reaction to antibiotic residues in food. [More]
Researchers reveal new approaches for antimalarial drug development

Researchers reveal new approaches for antimalarial drug development

Melbourne researchers are making progress towards new antimalarial drugs, after revealing how an antibiotic called emetine blocks the molecular machinery that produces the proteins required for malaria parasite survival. [More]
Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs

Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs

Wockhardt Limited today announces a major boost to the New Drug Discovery program in Anti-Infective research when two of its drugs, WCK 771 and WCK 2349, received the coveted Qualified Infectious Disease Product (QIDP) status from U.S. Food & Drug Administration. [More]
Scientists identify developmental on-off switch for Streptomyces

Scientists identify developmental on-off switch for Streptomyces

Scientists have identified the developmental on-off switch for Streptomyces, a group of soil microbes that produce more than two-thirds of the world's naturally derived antibiotic medicines. [More]
Mary Baxter outlines five key ways pharmacy leaders can help hospitals fulfill quality care mission

Mary Baxter outlines five key ways pharmacy leaders can help hospitals fulfill quality care mission

In part four of a blog series that addresses how to leverage a hospital pharmacy as a strategic asset, Mary Baxter, MBA, RPh., vice president and national practice leader for Cardinal Health's Innovation Delivery Solutions business, discusses how expanding patient access to quality pharmacy care can benefit both hospitals and patients. [More]
Rice University researchers confirm potent synthesis of natural tetracycline

Rice University researchers confirm potent synthesis of natural tetracycline

A fortuitous collaboration at Rice University has led to the total synthesis of a recently discovered natural antibiotic. [More]
Damp and mould in homes pose significant health risk to people with asthma

Damp and mould in homes pose significant health risk to people with asthma

Damp and mould in homes could pose a significant health risk to people with asthma according to a new study published in the Journal of Allergy and Clinical Immunology. [More]
Study: One in every 200 Ontarians diagnosed with inflammatory bowel disease

Study: One in every 200 Ontarians diagnosed with inflammatory bowel disease

One in every 200 Ontarians has been diagnosed with inflammatory bowel disease (IBD), with the number of people living with the disease increasing by 64 per cent between 1999 and 2008, according to a study by researchers at the Institute for Clinical Evaluative Sciences, the Children's Hospital of Eastern Ontario, and the Ottawa Hospital Research Institute. [More]
Contaminated blood cultures can serve as diagnostic predictor for more targeted antibiotics

Contaminated blood cultures can serve as diagnostic predictor for more targeted antibiotics

Some 30 percent of all positive hospital blood culture samples are discarded every day because they're "contaminated" - they reflect the presence of skin germs instead of specific disease-causing bacteria. [More]
Educating clinicians can reduce sepsis patient mortality and lower hospital costs

Educating clinicians can reduce sepsis patient mortality and lower hospital costs

Sepsis is the tenth leading cause of death in the United States, and new research published in the Journal for Healthcare Quality (JHQ) shows that educating clinicians about expediting diagnosis and administration of antibiotics can reduce sepsis patient mortality and lower hospital costs. [More]
Ruthigen gets DMC recommendation to begin RUT58-60 Phase 1/2 clinical trial

Ruthigen gets DMC recommendation to begin RUT58-60 Phase 1/2 clinical trial

Ruthigen Inc., a biopharmaceutical company focused on improving patient outcomes and reducing healthcare costs in invasive procedures, has announced that its lead drug candidate, RUT58-60, has received a recommendation from the Data Monitoring Committee to begin enrolling patients in the Company's planned Phase 1/2 clinical trial. [More]
Ohio State, Nationwide Children's Hospital partner with ENTvantage for diagnosing bacterial sinusitis

Ohio State, Nationwide Children's Hospital partner with ENTvantage for diagnosing bacterial sinusitis

The Ohio State University, through the Ohio State Innovation Foundation, and Nationwide Children's Hospital announced the signing of an exclusive, world-wide agreement with ENTvantage Diagnostics Inc. licensing a technology for rapid diagnosing of bacterial sinusitis. [More]